LABCORP HOLDINGS INC.·4

Feb 13, 12:56 PM ET

Parham Richelle P 4

Research Summary

AI-generated summary

Updated

Labcorp (LH) Director Richelle Parham Receives 897 Shares via RSU Vesting

What Happened

Richelle P. Parham, a director of Labcorp Holdings Inc. (LH), reported that 897 restricted stock units (RSUs) vested on February 11, 2026 and were converted into 897 shares (reported as a derivative exercise/conversion). The same filing shows a simultaneous disposition of 897 shares at $0.00, so no cash proceeds were reported. This activity reflects vested equity compensation rather than an open‑market buy or sale.

Key Details

  • Transaction date: February 11, 2026 (reported on Form 4 filed Feb 13, 2026).
  • Reported entries: 897 shares acquired by conversion (derivative, code M); 897 shares disposed at $0.00 (derivative).
  • Price/value: Acquisition listed as N/A; disposition listed at $0.00 — no cash proceeds reported.
  • Shares owned after transaction: Not specified in the filing.
  • Footnotes: F1 — each RSU equals the right to one share; F2 — the RSUs vested fully on Feb 11, 2026; F3 — the number reflects the aggregate RSUs held by the reporting person.
  • Timeliness: Filing was submitted two days after the transaction (within the typical 2-business-day Form 4 window).

Context

This was a conversion/vesting of RSUs (derivative code M), not a market sale or purchase. The reported disposition at $0.00 commonly reflects shares withheld or transferred to satisfy tax withholding or company remittance obligations, though the Form 4 does not explicitly state withholding here. For retail investors, RSU vesting is routine compensation and generally should not be read as a definitive signal of insider sentiment.